Epidemiology & Risk Factors

  • Definition: Development of secondary sexual characteristics in girls <8 yo or boys <9 yo.
  • Central PP (gonadotropin-dependent):
    • Girls: >90% idiopathic.
    • Boys: >90% secondary to CNS lesions (e.g., hypothalamic hamartoma, astrocytoma, trauma, cranial irradiation).
  • Peripheral PP (gonadotropin-independent):
    • Caused by autonomous sex hormone secretion (gonads, adrenals, or exogenous exposure).
    • Associated w/ McCune-Albright syndrome, CAH, Leydig cell tumors, granulosa cell tumors.

Clinical Features

  • Accelerated growth velocity & advanced skeletal maturation.
  • Girls: Thelarche (breast development), pubarche (pubic hair), menarche.
  • Boys: Testicular enlargement (testicular volume >4 mL or length >2.5 cm), phallic enlargement, pubarche, voice deepening, acne.
  • Signs of underlying pathology:
    • Café-au-lait spots w/ irregular borders (McCune-Albright).
    • Focal neurologic deficits, headaches, or signs of ↑ ICP (CNS tumor).
    • Virilization/hirsutism in girls (CAH or adrenal tumor).

Diagnosis

  • InitialBone age (BA) radiograph (left hand/wrist).
    • If BA ≤ chronological age (CA): Likely normal variant (e.g., premature thelarche/adrenarche). c
    • If BA > CA: Assess gonadotropins.
  • Key LabsBasal LH level.
    • If high: Central PP.
    • If low: Perform GnRH stimulation test.
      • LH rises (pubertal response) -> Central PP.
      • LH remains low (prepubertal response) -> Peripheral PP.
  • Imaging & Further Workup:
    • Central PP: Brain MRI w/ contrast (rule out hypothalamic hamartoma or CNS tumor).
    • Peripheral PP:
      • Girls: Pelvic US (ovarian cysts, granulosa cell tumor).
      • Boys: Testicular US (Leydig cell tumor).
      • Both: Serum DHEA-S, 17-OHP, testosterone levels (evaluate for CAH or adrenal tumors).

Differential Diagnostics

  • Premature adrenarche: Isolated pubic/axillary hair + body odor; BA normal or slightly advanced; normal basal LH.
  • Premature thelarche: Isolated breast development; BA matches CA; normal basal LH.
  • McCune-Albright syndrome: Triad of peripheral PP, irregular café-au-lait spots (coast of Maine), and polyostotic fibrous dysplasia (recurrent bone fractures).
  • Congenital Adrenal Hyperplasia (CAH): Peripheral PP + virilization + electrolyte abnormalities (salt-wasting 21-hydroxylase deficiency); elevated 17-OHP.

Management

  1. Central PP:
    • GnRH receptor agonists (e.g., depot leuprolide) continuous therapy to downregulate GnRH receptors, suppressing LH/FSH secretion.
    • Prevents premature epiphyseal fusion and maximizes adult height.
  2. Peripheral PP:
    • Treat primary cause.
    • Exogenous hormone exposure: Remove source.
    • CAH: Glucocorticoids (hydrocortisone).
    • Tumors (Leydig/granulosa cell): Surgical resection.
    • McCune-Albright: Aromatase inhibitors (e.g., anastrozole) or SERMs (e.g., tamoxifen).

Complications

  • Premature epiphyseal plate fusion resulting in short adult stature.
  • Psychosocial distress, bullying, and early sexualization.
  • CNS mass complications (e.g., hydrocephalus, vision loss) if central tumor etiology.

Benign Variants of Puberty

  • Benign variants of puberty are self-limiting, non-progressive patterns of early sexual development.
  • Bone age is typically normal (equal to chronological age), and growth velocity is within normal limits.

Epidemiology & Risk Factors

  • Premature Thelarche (PT): Girls <2 yo.
  • Premature Adrenarche (PA): Girls <8 yo, boys <9 yo; RFs: Obesity, SGA history.
  • Constitutional Delay of Growth and Adolescence (CDGA): Boys > girls; FHx of “late bloomers.”

Clinical Features

  • PT: Isolated breast development (bilateral or unilateral). No pubic/axillary hair.
  • PA: Isolated pubic/axillary hair, apocrine body odor, mild acne. Normal breast/testicular volume. c
  • CDGA: Delayed puberty (girls >13, boys >14), short stature, but normal growth velocity (parallel to growth curve).

Diagnosis

  • Initial: Bone Age (BA) X-ray (rules out true precocious puberty).
    • PT & PA: BA = Chronological age (normal).
    • CDGA: BA < Chronological age (delayed, matches height age).
  • Labs: Prepubertal LH/FSH. Slightly elevated DHEAS for age in PA (normal 17-OHP).
  • Growth Velocity: Normal (differentiates from true precocious puberty).

Differential Diagnostics

  • Central Precocious Puberty: Diff by advanced BA, accelerated growth, and ↑ LH (basal or GnRH-stimulated).
  • Peripheral Precocious Puberty: Diff by advanced BA, accelerated growth, and low LH (suppressed by peripheral sex steroids).
  • Hypogonadotropic Hypogonadism: Diff from CDGA by lack of growth spurt, persistently low gonadotropins, or associated anosmia (Kallmann).

Management

  • First-line (PT & PA): Reassurance and observation every 3-6 mos. c
  • First-line (CDGA): Reassurance & monitoring (reassure that normal final adult height is achieved).
  • Refractory/Psychosocial distress (CDGA in boys >14 yo): Short-course low-dose testosterone.

Complications

  • PA: Increased risk of PCOS and metabolic syndrome later in life.
  • CDGA: Severe psychosocial distress, low self-esteem.